Covid-19 Impact on Metabolomics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Metabolomics, including the following market information:
Major competitors identified in this market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Biocrates Life Sciences AG, Shimadzu Corporation, Waters Corporation, Human Metabolome Technologies, Inc., LECO Corporation, Metabolon, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, etc.
Based on the Region:
- Global Metabolomics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Metabolomics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Metabolomics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Metabolomics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Biocrates Life Sciences AG, Shimadzu Corporation, Waters Corporation, Human Metabolome Technologies, Inc., LECO Corporation, Metabolon, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Introduction
- Separation Techniques
- Detection Techniques
- Introduction
- Drug Assessment
- Biomarker Discovery
- Nutrigenomics
- Clinical toxicology
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Metabolomics Industry
1.7 COVID-19 Impact: Metabolomics Market Trends
2 GLOBAL METABOLOMICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Metabolomics Business Impact Assessment - COVID-19
2.1.1 Global Metabolomics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Metabolomics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Metabolomics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Metabolomics Headquarters and Area Served
3.3 Date of Key Players Enter into Metabolomics Market
3.4 Key Players Metabolomics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON METABOLOMICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Introduction
1.4.2 Separation Techniques
1.4.3 Detection Techniques
4.2 By Type, Global Metabolomics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON METABOLOMICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Introduction
5.5.2 Drug Assessment
5.5.3 Biomarker Discovery
5.5.4 Nutrigenomics
5.5.5 Clinical toxicology
5.5.6 Others
5.2 By Application, Global Metabolomics Market Size, 2019-2021
5.2.1 By Application, Global Metabolomics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Thermo Fisher Scientific, Inc. Business Overview
7.1.2 Thermo Fisher Scientific, Inc. Metabolomics Quarterly Revenue, 2020
7.1.3 Thermo Fisher Scientific, Inc. Metabolomics Product Introduction
7.1.4 Thermo Fisher Scientific, Inc. Response to COVID-19 and Related Developments
7.2 Agilent Technologies, Inc.
7.2.1 Agilent Technologies, Inc. Business Overview
7.2.2 Agilent Technologies, Inc. Metabolomics Quarterly Revenue, 2020
7.2.3 Agilent Technologies, Inc. Metabolomics Product Introduction
7.2.4 Agilent Technologies, Inc. Response to COVID-19 and Related Developments
7.3 Biocrates Life Sciences AG
7.3.1 Biocrates Life Sciences AG Business Overview
7.3.2 Biocrates Life Sciences AG Metabolomics Quarterly Revenue, 2020
7.3.3 Biocrates Life Sciences AG Metabolomics Product Introduction
7.3.4 Biocrates Life Sciences AG Response to COVID-19 and Related Developments
7.4 Shimadzu Corporation
7.4.1 Shimadzu Corporation Business Overview
7.4.2 Shimadzu Corporation Metabolomics Quarterly Revenue, 2020
7.4.3 Shimadzu Corporation Metabolomics Product Introduction
7.4.4 Shimadzu Corporation Response to COVID-19 and Related Developments
7.5 Waters Corporation
7.5.1 Waters Corporation Business Overview
7.5.2 Waters Corporation Metabolomics Quarterly Revenue, 2020
7.5.3 Waters Corporation Metabolomics Product Introduction
7.5.4 Waters Corporation Response to COVID-19 and Related Developments
7.6 Human Metabolome Technologies, Inc.
7.6.1 Human Metabolome Technologies, Inc. Business Overview
7.6.2 Human Metabolome Technologies, Inc. Metabolomics Quarterly Revenue, 2020
7.6.3 Human Metabolome Technologies, Inc. Metabolomics Product Introduction
7.6.4 Human Metabolome Technologies, Inc. Response to COVID-19 and Related Developments
7.7 LECO Corporation
7.7.1 LECO Corporation Business Overview
7.7.2 LECO Corporation Metabolomics Quarterly Revenue, 2020
7.7.3 LECO Corporation Metabolomics Product Introduction
7.7.4 LECO Corporation Response to COVID-19 and Related Developments
7.8 Metabolon, Inc.
7.8.1 Metabolon, Inc. Business Overview
7.8.2 Metabolon, Inc. Metabolomics Quarterly Revenue, 2020
7.8.3 Metabolon, Inc. Metabolomics Product Introduction
7.8.4 Metabolon, Inc. Response to COVID-19 and Related Developments
7.9 Bio-Rad Laboratories, Inc.
7.9.1 Bio-Rad Laboratories, Inc. Business Overview
7.9.2 Bio-Rad Laboratories, Inc. Metabolomics Quarterly Revenue, 2020
7.9.3 Bio-Rad Laboratories, Inc. Metabolomics Product Introduction
7.9.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
7.10 Bruker Corporation
7.10.1 Bruker Corporation Business Overview
7.10.2 Bruker Corporation Metabolomics Quarterly Revenue, 2020
7.10.3 Bruker Corporation Metabolomics Product Introduction
7.10.4 Bruker Corporation Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Metabolomics Industry
1.7 COVID-19 Impact: Metabolomics Market Trends
2 GLOBAL METABOLOMICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Metabolomics Business Impact Assessment - COVID-19
2.1.1 Global Metabolomics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Metabolomics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Metabolomics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Metabolomics Headquarters and Area Served
3.3 Date of Key Players Enter into Metabolomics Market
3.4 Key Players Metabolomics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON METABOLOMICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Introduction
1.4.2 Separation Techniques
1.4.3 Detection Techniques
4.2 By Type, Global Metabolomics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON METABOLOMICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Introduction
5.5.2 Drug Assessment
5.5.3 Biomarker Discovery
5.5.4 Nutrigenomics
5.5.5 Clinical toxicology
5.5.6 Others
5.2 By Application, Global Metabolomics Market Size, 2019-2021
5.2.1 By Application, Global Metabolomics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Thermo Fisher Scientific, Inc. Business Overview
7.1.2 Thermo Fisher Scientific, Inc. Metabolomics Quarterly Revenue, 2020
7.1.3 Thermo Fisher Scientific, Inc. Metabolomics Product Introduction
7.1.4 Thermo Fisher Scientific, Inc. Response to COVID-19 and Related Developments
7.2 Agilent Technologies, Inc.
7.2.1 Agilent Technologies, Inc. Business Overview
7.2.2 Agilent Technologies, Inc. Metabolomics Quarterly Revenue, 2020
7.2.3 Agilent Technologies, Inc. Metabolomics Product Introduction
7.2.4 Agilent Technologies, Inc. Response to COVID-19 and Related Developments
7.3 Biocrates Life Sciences AG
7.3.1 Biocrates Life Sciences AG Business Overview
7.3.2 Biocrates Life Sciences AG Metabolomics Quarterly Revenue, 2020
7.3.3 Biocrates Life Sciences AG Metabolomics Product Introduction
7.3.4 Biocrates Life Sciences AG Response to COVID-19 and Related Developments
7.4 Shimadzu Corporation
7.4.1 Shimadzu Corporation Business Overview
7.4.2 Shimadzu Corporation Metabolomics Quarterly Revenue, 2020
7.4.3 Shimadzu Corporation Metabolomics Product Introduction
7.4.4 Shimadzu Corporation Response to COVID-19 and Related Developments
7.5 Waters Corporation
7.5.1 Waters Corporation Business Overview
7.5.2 Waters Corporation Metabolomics Quarterly Revenue, 2020
7.5.3 Waters Corporation Metabolomics Product Introduction
7.5.4 Waters Corporation Response to COVID-19 and Related Developments
7.6 Human Metabolome Technologies, Inc.
7.6.1 Human Metabolome Technologies, Inc. Business Overview
7.6.2 Human Metabolome Technologies, Inc. Metabolomics Quarterly Revenue, 2020
7.6.3 Human Metabolome Technologies, Inc. Metabolomics Product Introduction
7.6.4 Human Metabolome Technologies, Inc. Response to COVID-19 and Related Developments
7.7 LECO Corporation
7.7.1 LECO Corporation Business Overview
7.7.2 LECO Corporation Metabolomics Quarterly Revenue, 2020
7.7.3 LECO Corporation Metabolomics Product Introduction
7.7.4 LECO Corporation Response to COVID-19 and Related Developments
7.8 Metabolon, Inc.
7.8.1 Metabolon, Inc. Business Overview
7.8.2 Metabolon, Inc. Metabolomics Quarterly Revenue, 2020
7.8.3 Metabolon, Inc. Metabolomics Product Introduction
7.8.4 Metabolon, Inc. Response to COVID-19 and Related Developments
7.9 Bio-Rad Laboratories, Inc.
7.9.1 Bio-Rad Laboratories, Inc. Business Overview
7.9.2 Bio-Rad Laboratories, Inc. Metabolomics Quarterly Revenue, 2020
7.9.3 Bio-Rad Laboratories, Inc. Metabolomics Product Introduction
7.9.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
7.10 Bruker Corporation
7.10.1 Bruker Corporation Business Overview
7.10.2 Bruker Corporation Metabolomics Quarterly Revenue, 2020
7.10.3 Bruker Corporation Metabolomics Product Introduction
7.10.4 Bruker Corporation Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Metabolomics Assessment
Table 9. COVID-19 Impact: Metabolomics Market Trends
Table 10. COVID-19 Impact Global Metabolomics Market Size
Table 11. Global Metabolomics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Metabolomics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Metabolomics Market Growth Drivers
Table 14. Global Metabolomics Market Restraints
Table 15. Global Metabolomics Market Opportunities
Table 16. Global Metabolomics Market Challenges
Table 17. By Players, Metabolomics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Metabolomics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Metabolomics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Metabolomics Market
Table 21. Key Players Metabolomics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Metabolomics Market Size 2019-2021, (US$ Million)
Table 24. Global Metabolomics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Metabolomics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Metabolomics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Metabolomics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Metabolomics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Metabolomics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Metabolomics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Metabolomics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Metabolomics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Metabolomics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Metabolomics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Metabolomics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Metabolomics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Metabolomics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Metabolomics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Metabolomics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Metabolomics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Metabolomics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Metabolomics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Metabolomics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Metabolomics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Metabolomics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Metabolomics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Metabolomics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Metabolomics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Metabolomics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Metabolomics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Metabolomics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Metabolomics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Metabolomics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Metabolomics Market Size, 2019-2021 (US$ Million)
Table 57. Thermo Fisher Scientific, Inc. Business Overview
Table 58. Thermo Fisher Scientific, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Thermo Fisher Scientific, Inc. Metabolomics Product
Table 60. Thermo Fisher Scientific, Inc. Response to COVID-19 and Related Developments
Table 61. Agilent Technologies, Inc. Business Overview
Table 62. Agilent Technologies, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Agilent Technologies, Inc. Metabolomics Product
Table 64. Agilent Technologies, Inc. Response to COVID-19 and Related Developments
Table 65. Biocrates Life Sciences AG Business Overview
Table 66. Biocrates Life Sciences AG Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Biocrates Life Sciences AG Metabolomics Product
Table 68. Biocrates Life Sciences AG Response to COVID-19 and Related Developments
Table 69. Shimadzu Corporation Business Overview
Table 70. Shimadzu Corporation Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Shimadzu Corporation Metabolomics Product
Table 72. Shimadzu Corporation Response to COVID-19 and Related Developments
Table 73. Waters Corporation Business Overview
Table 74. Waters Corporation Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Waters Corporation Metabolomics Product
Table 76. Waters Corporation Response to COVID-19 and Related Developments
Table 77. Human Metabolome Technologies, Inc. Business Overview
Table 78. Human Metabolome Technologies, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Human Metabolome Technologies, Inc. Metabolomics Product
Table 80. Human Metabolome Technologies, Inc. Response to COVID-19 and Related Developments
Table 81. LECO Corporation Business Overview
Table 82. LECO Corporation Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. LECO Corporation Metabolomics Product
Table 84. LECO Corporation Response to COVID-19 and Related Developments
Table 85. Metabolon, Inc. Business Overview
Table 86. Metabolon, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Metabolon, Inc. Metabolomics Product
Table 88. Metabolon, Inc. Response to COVID-19 and Related Developments
Table 89. Bio-Rad Laboratories, Inc. Business Overview
Table 90. Bio-Rad Laboratories, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Bio-Rad Laboratories, Inc. Metabolomics Product
Table 92. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
Table 93. Bruker Corporation Business Overview
Table 94. Bruker Corporation Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Bruker Corporation Metabolomics Product
Table 96. Bruker Corporation Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Metabolomics Assessment
Table 9. COVID-19 Impact: Metabolomics Market Trends
Table 10. COVID-19 Impact Global Metabolomics Market Size
Table 11. Global Metabolomics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Metabolomics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Metabolomics Market Growth Drivers
Table 14. Global Metabolomics Market Restraints
Table 15. Global Metabolomics Market Opportunities
Table 16. Global Metabolomics Market Challenges
Table 17. By Players, Metabolomics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Metabolomics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Metabolomics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Metabolomics Market
Table 21. Key Players Metabolomics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Metabolomics Market Size 2019-2021, (US$ Million)
Table 24. Global Metabolomics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Metabolomics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Metabolomics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Metabolomics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Metabolomics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Metabolomics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Metabolomics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Metabolomics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Metabolomics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Metabolomics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Metabolomics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Metabolomics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Metabolomics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Metabolomics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Metabolomics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Metabolomics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Metabolomics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Metabolomics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Metabolomics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Metabolomics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Metabolomics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Metabolomics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Metabolomics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Metabolomics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Metabolomics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Metabolomics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Metabolomics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Metabolomics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Metabolomics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Metabolomics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Metabolomics Market Size, 2019-2021 (US$ Million)
Table 57. Thermo Fisher Scientific, Inc. Business Overview
Table 58. Thermo Fisher Scientific, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Thermo Fisher Scientific, Inc. Metabolomics Product
Table 60. Thermo Fisher Scientific, Inc. Response to COVID-19 and Related Developments
Table 61. Agilent Technologies, Inc. Business Overview
Table 62. Agilent Technologies, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Agilent Technologies, Inc. Metabolomics Product
Table 64. Agilent Technologies, Inc. Response to COVID-19 and Related Developments
Table 65. Biocrates Life Sciences AG Business Overview
Table 66. Biocrates Life Sciences AG Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Biocrates Life Sciences AG Metabolomics Product
Table 68. Biocrates Life Sciences AG Response to COVID-19 and Related Developments
Table 69. Shimadzu Corporation Business Overview
Table 70. Shimadzu Corporation Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Shimadzu Corporation Metabolomics Product
Table 72. Shimadzu Corporation Response to COVID-19 and Related Developments
Table 73. Waters Corporation Business Overview
Table 74. Waters Corporation Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Waters Corporation Metabolomics Product
Table 76. Waters Corporation Response to COVID-19 and Related Developments
Table 77. Human Metabolome Technologies, Inc. Business Overview
Table 78. Human Metabolome Technologies, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Human Metabolome Technologies, Inc. Metabolomics Product
Table 80. Human Metabolome Technologies, Inc. Response to COVID-19 and Related Developments
Table 81. LECO Corporation Business Overview
Table 82. LECO Corporation Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. LECO Corporation Metabolomics Product
Table 84. LECO Corporation Response to COVID-19 and Related Developments
Table 85. Metabolon, Inc. Business Overview
Table 86. Metabolon, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Metabolon, Inc. Metabolomics Product
Table 88. Metabolon, Inc. Response to COVID-19 and Related Developments
Table 89. Bio-Rad Laboratories, Inc. Business Overview
Table 90. Bio-Rad Laboratories, Inc. Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Bio-Rad Laboratories, Inc. Metabolomics Product
Table 92. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
Table 93. Bruker Corporation Business Overview
Table 94. Bruker Corporation Metabolomics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Bruker Corporation Metabolomics Product
Table 96. Bruker Corporation Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Metabolomics Product Picture
Figure 2. Metabolomics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Metabolomics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Metabolomics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Metabolomics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Metabolomics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Metabolomics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Metabolomics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Metabolomics Market Size Market Share, 2019-2021
Figure 1. Metabolomics Product Picture
Figure 2. Metabolomics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Metabolomics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Metabolomics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Metabolomics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Metabolomics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Metabolomics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Metabolomics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Metabolomics Market Size Market Share, 2019-2021
